Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    "22q13.3 deletion syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"22q13.3 deletion syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
Condition: Phelan-McDermid Syndrome
Interventions: Drug: Oxytocin;   Drug: Saline
2 Completed Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment
Condition: Phelan-McDermid Syndrome
Intervention:
3 Active, not recruiting Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
Conditions: 22q13 Deletion Syndrome;   Phelan-McDermid Syndrome
Interventions: Drug: Insulin-Like Growth Factor-1 (IGF-1);   Drug: Normal saline
4 Recruiting Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Conditions: Phelan-McDermid Syndrome;   Autism Spectrum Disorder;   Intellectual Disability
Intervention:

Study has passed its completion date and status has not been verified in more than two years.